All posts by: Michael Zand

About Michael Zand

New Immune Cell May Predict Which Mesothelioma Patients Will Benefit From Immunotherapy – MesotheliomaHelp.org (blog)

Continue reading

2017-09-21 NEWS

MesotheliomaHelp.org (blog)

New Immune Cell May Predict Which Mesothelioma Patients Will Benefit From Immunotherapy
MesotheliomaHelp.org (blog)
Now, one team of researchers is looking more closely at immune cells to predict which lung cancer patients will benefit most from immunotherapy, and the findings look hopeful for mesothelioma patients as well. In a study from Cancer Research UK, …
Immunotherapy Drugs Market Size and Forecast, 2016 – 2024satPRnews (press release)
Scientists here testing new treatment for ovarian cancerChina Post

all 4 news articles »

Continue reading

2017-09-21 NEWS

Drug Discovery & Development

CRISPR Developer Awarded Lemelson-MIT Prize
Drug Discovery & Development
Dr. Feng Zhang, a pioneer of the revolutionary CRISPR gene editing technology, TAL effectors, and optogenics, has just been announced as the recipient of the 2017 $500,000 Lemelson-MIT Prize, the largest cash prize for invention in the United States.

Continue reading

2017-09-21 NEWS

MIT Technology Review

Even at $500K, Gene Therapy Could Be a Bargain for Some Diseases
MIT Technology Review
The U.S. Food and Drug Administration recently approved what it called the “first gene therapy” in the country. The therapy, called Kymriah and made by Novartis, uses a patient’s own cells—which are genetically modified outside the body—to treat a
Novel Gene Therapy and Antisense Drugs to Offer Effective Cancer CureTMR Research Blog (press release) (blog)

all 3 news articles »

Continue reading

2017-09-21 NEWS

DARPA Meeting Looks at Biotech’s Promise
Occupational Health and Safety
BTO brought together DARPA-funded researchers to describe their research and results, including speakers from Ecovative; Phylagen; MIT Broad Foundry for Synthetic Biology; Massachusetts General Hospital/Harvard Medical School; Seromics, Inc.; RenBio …